Lung Adenocarcinoma: Guiding EGFR-targeted Therapy and Beyond

Modern Pathology - United Kingdom
doi 10.1038/modpathol.3801018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC